Life sciences · Preprint
arXiv · September 22, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Preprint.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Saliency maps are widely used to explain deep learning predictions in medical imaging, yet visually plausible explanations do not necessarily reflect a model's true decision process and may therefore mislead clinicians. We investigate this problem using a Vision Transformer-based breast MRI classifier trained on the ODELIA Breast MRI Challenge dataset and evaluate multiple saliency methods, including Last-layer Attention, Attention Rollout, Grad-SAM, Gradient Attention Rollout, GMAR, Grad-CAM, and HiResCAM. Our study highlights two often-overlooked challenges in perturbation-based faithfulness evaluation. First, method rankings depend strongly on the perturbation strategy, varying across intensity-based perturbations and transformer-based attention masking. Second, benchmarking saliency methods requires distinguishing between class-specific and class-agnostic explanations. To enable fair comparisons, we introduce non-class-specific variants of gradient-based methods and evaluate both settings separately. Across protocols, Grad-CAM and Gradient Attention Rollout consistently emerged as the strongest class-specific methods, although their relative ranking depended on the evaluation design. These findings expose important limitations of current saliency-based explainability approaches and highlight the need for more robust and standardized evaluation frameworks for trustworthy clinical AI systems.